Cargando…

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron

Parkinson’s disease dementia (PDD) is a common complication of Parkinson’s disease that seriously affects patients’ health and quality of life. At present, the process and pathological mechanisms of PDD remain controversial, which hinders the development of treatments. An increasing number of clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jiajun, Fan, Yaohua, Wu, Peipei, Huang, Zifeng, Li, Xinrong, Zhao, Lijun, Ji, Yichun, Zhu, Meiling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542689/ https://www.ncbi.nlm.nih.gov/pubmed/34707492 http://dx.doi.org/10.3389/fnagi.2021.743754

Ejemplares similares

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Experimental Models of Cognitive Impairment for Use in Parkinson’s Disease Research: The Distance Between Reality and Ideal
por: Fan, Yaohua, et al.
Publicado: (2021)

Corrigendum: Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal
por: Fan, Yaohua, et al.
Publicado: (2021)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

Chronic Cerebral Hypoperfusion Aggravates Parkinson's Disease Dementia-Like Symptoms and Pathology in 6-OHDA-Lesioned Rat through Interfering with Sphingolipid Metabolism
por: Fan, Yaohua, et al.
Publicado: (2022)

Investigating the Pathogenic Interplay of Alpha-Synuclein, Tau, and Amyloid Beta in Lewy Body Dementia: Insights from Viral-Mediated Overexpression in Transgenic Mouse Models
por: Lim, Melina J., et al.
Publicado: (2023)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
por: Köppen, Janett, et al.
Publicado: (2020)

Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core
por: Vacchi, Elena, et al.
Publicado: (2020)

Sorting Nexin 5 Plays an Important Role in Promoting Ferroptosis in Parkinson's Disease
por: Huang, Zifeng, et al.
Publicado: (2022)

Brainstem Quadruple Aberrant Hyperphosphorylated Tau, Beta-Amyloid, Alpha-Synuclein and TDP-43 Pathology, Stress and Sleep Behavior Disorders
por: Calderón-Garcidueñas, Lilian, et al.
Publicado: (2021)

Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
por: Miller, Rebecca L., et al.
Publicado: (2022)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
por: Deleidi, Michela, et al.
Publicado: (2012)

Using an NMR metabolomics approach to investigate the pathogenicity of amyloid-beta and alpha-synuclein
por: Phelan, M. M., et al.
Publicado: (2017)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology
por: Kim, Taewon, et al.
Publicado: (2022)

Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases
por: Albus, Alexandra, et al.
Publicado: (2019)

Cerebrospinal Fluid Amyloid β(1-42), Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s Disease
por: Kang, Ju-Hee
Publicado: (2016)

Protein aggregation containing beta-amyloid, alpha-synuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure
por: Chaves, Rodrigo S, et al.
Publicado: (2010)

Studies on alpha-synuclein and islet amyloid polypeptide interaction
por: Wang, Ye, et al.
Publicado: (2023)

Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia
por: Yedlapudi, Deepthi, et al.
Publicado: (2019)

Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes
por: Kim, Dong Won, et al.
Publicado: (2022)

Beta-amyloid imaging in dementia
por: Chun, Kyung Ah
Publicado: (2018)

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

RNA sequestration driven by amyloid formation: the alpha synuclein case
por: Rupert, Jakob, et al.
Publicado: (2023)

Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia
por: Arber, Charles, et al.
Publicado: (2021)

A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias
por: Said, Harun Muayad, et al.
Publicado: (2022)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
por: Therriault, Joseph, et al.
Publicado: (2021)

Assessment of the efficacy of different procedures that remove and disassemble alpha-synuclein, tau and A-beta fibrils from laboratory material and surfaces
por: Fenyi, Alexis, et al.
Publicado: (2018)

Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis
por: Huang, Zifeng, et al.
Publicado: (2021)

Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins
por: Vaneyck, Jonathan, et al.
Publicado: (2021)

S100A9 Alters the Pathway of Alpha-Synuclein Amyloid Aggregation
por: Toleikis, Zigmantas, et al.
Publicado: (2021)

Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia
por: Li, Mengzhu, et al.
Publicado: (2022)

Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
por: Barba, Lorenzo, et al.
Publicado: (2022)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

A Powerful Yeast Model to Investigate the Synergistic Interaction of α-Synuclein and Tau in Neurodegeneration
por: Ciaccioli, Gianmario, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hg3id94jfd1k63e6lm18ilai49